Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Sushanth Reddy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4150-9458; OpenAlex author ID A5021909013. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
78
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers

Papers 13

  1. Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-Analysis. Co-author DOI 10.1016/j.jss.2025.04.042↗
  2. Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-analysis' Jou… Co-author DOI 10.1016/j.jss.2025.10.015↗
  3. An Analysis on the Effect of Income Changes in the Resection of Early-Stage Pancreatic Adenocarcinoma. Last author DOI 10.1177/00031348241256058↗
  4. Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? Last author DOI 10.1016/j.jss.2022.11.031↗
  5. Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? Last author DOI 10.1016/j.amjsurg.2022.04.004↗
  6. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. Co-author DOI 10.1016/j.hpb.2022.05.003↗
  7. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2021.0017↗
  8. Healthcare disparities in outcomes of patients with resectable pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2018.12.007↗
  9. Pancreatic Adenocarcinoma, Version 1.2019. Co-author DOI 10.6004/jnccn.2019.0014↗
  10. Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base. Co-author DOI 10.1016/j.amjsurg.2017.06.036↗
  11. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
  12. Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. First author DOI 10.2214/ajr.13.12439↗
  13. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Co-author DOI 10.6004/jnccn.2014.0106↗

Closest collaborators

The 25 strongest of 78 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Bart Rose · 6 shared papers, 2022–2025 · strength 1.27
  2. Vikas Dudeja · 6 shared papers, 2022–2025 · strength 1.27
  3. Martin J. Heslin · 4 shared papers, 2017–2025 · strength 0.73
  4. Ahmer Irfan · 3 shared papers, 2022–2024 · strength 0.60
  5. Michelle M. Holland · 2 shared papers, 2025 · strength 0.54
  6. Annabelle L. Fonseca · 2 shared papers, 2025 · strength 0.54
  7. Chandler A. Annesi · 2 shared papers, 2025 · strength 0.54
  8. Selwyn Maurice Vickers · 3 shared papers, 2017–2023 · strength 0.40
  9. Olumide B. Gbolahan · 2 shared papers, 2022–2023 · strength 0.32
  10. Hua Amanda Fang · 2 shared papers, 2022–2023 · strength 0.32
  11. William G. Hawkins · 4 shared papers, 2014–2021 · strength 0.22
  12. Andrew H. Ko · 4 shared papers, 2014–2021 · strength 0.22
  13. Brian G. Czito · 4 shared papers, 2014–2021 · strength 0.22
  14. Robert A. Wolff · 4 shared papers, 2014–2021 · strength 0.22
  15. Stephen W. Behrman · 4 shared papers, 2014–2021 · strength 0.22
  16. Eric K. Nakakura · 4 shared papers, 2014–2021 · strength 0.22
  17. Mokenge Peter Malafa · 4 shared papers, 2014–2021 · strength 0.22
  18. Brian Matthew Wolpin · 4 shared papers, 2014–2021 · strength 0.22
  19. Andrew M. Lowy · 4 shared papers, 2014–2021 · strength 0.22
  20. Vincent M. Chung · 4 shared papers, 2014–2021 · strength 0.22
  21. Margaret A. Tempero · 4 shared papers, 2014–2021 · strength 0.22
  22. Al B. Benson · 4 shared papers, 2014–2021 · strength 0.22
  23. Elena Gabriela Chiorean · 4 shared papers, 2014–2021 · strength 0.22
  24. Mahmoud M. Al-Hawary · 3 shared papers, 2017–2021 · strength 0.19
  25. Noelle K. LoConte · 3 shared papers, 2017–2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.